Brentuximab Vedotin,Dacarbazine,Doxorubicin,Filgrastim,Nivolumab,Pegfilgrastim,vinblastine
amgen,bms,seagen
['cml']
wise words from peter borchmann - need to wait a bit longer to be sure that the early benefit of avd-n is durable as mechanism of pd1i clearly v diff from chemo / bv. #17icml #icml23 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.